News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aspirin Cuts Colon Cancer Risk, Harvard Medical School Study Suggests


6/26/2013 7:32:28 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Aspirin’s benefit in thwarting colon cancer is driven by a gene mutation that makes tumor cells less sensitive to the drug’s effects, according to a study that may lead to personalized prevention strategies. Developing colon cancer with a mutation of the gene BRAF was similar for both regular aspirin users and non-users, according to research published today in the Journal of the American Medical Association. Regular aspirin users had a 27 percent reduced risk of developing cancer without the mutation compared with those who didn’t regularly take the drug, the study found.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Bloomberg
Read at ScienceDaily
Read at EurekAlert!
Read at Fox News
Read at BusinessWeek

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES